Candriam SCA’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,846
| Closed | -$390K | – | 731 |
|
|
2023
Q1 | $390K | Sell |
5,846
-1,796
| -24% | -$120K | ﹤0.01% | 827 |
|
|
2022
Q4 | $627K | Sell |
7,642
-1,342
| -15% | -$110K | ﹤0.01% | 779 |
|
|
2022
Q3 | $849K | Buy |
+8,984
| New | +$849K | 0.01% | 743 |
|
|
2016
Q2 | – | Sell |
-2,220
| Closed | -$1.05M | – | 659 |
|
|
2016
Q1 | $1.05M | Buy |
+2,220
| New | +$1.05M | 0.03% | 422 |
|
|
2015
Q4 | – | Sell |
-1,628
| Closed | -$1.28M | – | 580 |
|
|
2015
Q3 | $1.28M | Buy |
1,628
+1,028
| +171% | +$808K | 0.03% | 407 |
|
|
2015
Q2 | $791K | Buy |
+600
| New | +$791K | 0.02% | 477 |
|